Impetus Grants
Fast, low-overhead grants for big-if-true longevity research. Next round: funding the missing datasets that determine how soon AI can help discover aging drugs.
Our projects
We’re industrializing longevity: building a field whose ability to discover, test, and deliver medicines compounds with each advance, toward a future where aging no longer cuts human lives short.
A longevity do tank
The future we want has to be built. We turn a long-term vision for longevity into concrete plans, then take on the work of making them happen.
Backing people and ideas
Talent Bridge
Awards and mentorship help researchers complete projects and relocate to the United States to work on longevity.
Open proposals
We analyze the flow of innovation in longevity to identify the projects that would have the biggest impact on progress, and turn those into proposals and whitepapers.
If you’d like to collaborate or support these projects, contact us.
Clock Assessment Program
We believe validating aging clocks and biomarkers is a high priority for longevity. CAP would test whether clocks can predict mouse lifespan early enough to speed up iteration in preclinical studies.
MCARD
Testing drugs one disease at a time can miss their broader benefits. MCARD would evaluate biomarkers of shared disease processes so clinical trials can assess effects across multiple age-related diseases.
Longevity Nexus
The highest concentration of talent in longevity, working on projects that add more years to life.
Tools and analyses
We share the analyses and tools that let us understand that field's progress. Our age-related disease overview helps new longevity companies choose which diseases to target, and our trial-size calculator helps them plan studies.
